Food and drug administration tobacco regulation and product judgments

Annette R. Kaufman, Lila J Rutten, Mark Parascandola, Kelly D. Blake, Erik M. Augustson

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background The Family Smoking Prevention and Tobacco Control Act granted the Food and Drug Administration (FDA) the authority to regulate tobacco products in the U.S. However, little is known about how regulation may be related to judgments about tobacco product-related risks. Purpose To understand how FDA tobacco regulation beliefs are associated with judgments about tobacco product-related risks. Methods The Health Information National Trends Survey is a national survey of the U.S. Adult population. Data used in this analysis were collected from October 2012 through January 2013 (N=3,630) by mailed questionnaire and analyzed in 2013. Weighted bivariate chi-square analyses were used to assess associations among FDA regulation belief, tobacco harm judgments, sociodemographics, and smoking status. A weighted multinomial logistic regression was conducted where FDA regulation belief was regressed on tobacco product judgments, controlling for sociodemographic variables and smoking status. Results About 41% believed that the FDA regulates tobacco products in the U.S., 23.6% reported the FDA does not, and 35.3% did not know. Chi-square analyses showed that smoking status was significantly related to harm judgments about electronic cigarettes (p<0.0001). The multinomial logistic regression revealed that uncertainty about FDA regulation was associated with tobacco product harm judgment uncertainty. Conclusions Tobacco product harm perceptions are associated with beliefs about tobacco product regulation by the FDA. These findings suggest the need for increased public awareness and understanding of the role of tobacco product regulation in protecting public health.

Original languageEnglish (US)
Pages (from-to)445-451
Number of pages7
JournalAmerican Journal of Preventive Medicine
Volume48
Issue number4
DOIs
StatePublished - Apr 1 2015

Fingerprint

United States Food and Drug Administration
Tobacco Products
Drug and Narcotic Control
Smoking
Uncertainty
Tobacco
Logistic Models
Public Health
Health

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Epidemiology

Cite this

Food and drug administration tobacco regulation and product judgments. / Kaufman, Annette R.; Rutten, Lila J; Parascandola, Mark; Blake, Kelly D.; Augustson, Erik M.

In: American Journal of Preventive Medicine, Vol. 48, No. 4, 01.04.2015, p. 445-451.

Research output: Contribution to journalArticle

Kaufman, Annette R. ; Rutten, Lila J ; Parascandola, Mark ; Blake, Kelly D. ; Augustson, Erik M. / Food and drug administration tobacco regulation and product judgments. In: American Journal of Preventive Medicine. 2015 ; Vol. 48, No. 4. pp. 445-451.
@article{e2477d28e4034cf2ae794753097d5cd7,
title = "Food and drug administration tobacco regulation and product judgments",
abstract = "Background The Family Smoking Prevention and Tobacco Control Act granted the Food and Drug Administration (FDA) the authority to regulate tobacco products in the U.S. However, little is known about how regulation may be related to judgments about tobacco product-related risks. Purpose To understand how FDA tobacco regulation beliefs are associated with judgments about tobacco product-related risks. Methods The Health Information National Trends Survey is a national survey of the U.S. Adult population. Data used in this analysis were collected from October 2012 through January 2013 (N=3,630) by mailed questionnaire and analyzed in 2013. Weighted bivariate chi-square analyses were used to assess associations among FDA regulation belief, tobacco harm judgments, sociodemographics, and smoking status. A weighted multinomial logistic regression was conducted where FDA regulation belief was regressed on tobacco product judgments, controlling for sociodemographic variables and smoking status. Results About 41{\%} believed that the FDA regulates tobacco products in the U.S., 23.6{\%} reported the FDA does not, and 35.3{\%} did not know. Chi-square analyses showed that smoking status was significantly related to harm judgments about electronic cigarettes (p<0.0001). The multinomial logistic regression revealed that uncertainty about FDA regulation was associated with tobacco product harm judgment uncertainty. Conclusions Tobacco product harm perceptions are associated with beliefs about tobacco product regulation by the FDA. These findings suggest the need for increased public awareness and understanding of the role of tobacco product regulation in protecting public health.",
author = "Kaufman, {Annette R.} and Rutten, {Lila J} and Mark Parascandola and Blake, {Kelly D.} and Augustson, {Erik M.}",
year = "2015",
month = "4",
day = "1",
doi = "10.1016/j.amepre.2014.10.026",
language = "English (US)",
volume = "48",
pages = "445--451",
journal = "American Journal of Preventive Medicine",
issn = "0749-3797",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Food and drug administration tobacco regulation and product judgments

AU - Kaufman, Annette R.

AU - Rutten, Lila J

AU - Parascandola, Mark

AU - Blake, Kelly D.

AU - Augustson, Erik M.

PY - 2015/4/1

Y1 - 2015/4/1

N2 - Background The Family Smoking Prevention and Tobacco Control Act granted the Food and Drug Administration (FDA) the authority to regulate tobacco products in the U.S. However, little is known about how regulation may be related to judgments about tobacco product-related risks. Purpose To understand how FDA tobacco regulation beliefs are associated with judgments about tobacco product-related risks. Methods The Health Information National Trends Survey is a national survey of the U.S. Adult population. Data used in this analysis were collected from October 2012 through January 2013 (N=3,630) by mailed questionnaire and analyzed in 2013. Weighted bivariate chi-square analyses were used to assess associations among FDA regulation belief, tobacco harm judgments, sociodemographics, and smoking status. A weighted multinomial logistic regression was conducted where FDA regulation belief was regressed on tobacco product judgments, controlling for sociodemographic variables and smoking status. Results About 41% believed that the FDA regulates tobacco products in the U.S., 23.6% reported the FDA does not, and 35.3% did not know. Chi-square analyses showed that smoking status was significantly related to harm judgments about electronic cigarettes (p<0.0001). The multinomial logistic regression revealed that uncertainty about FDA regulation was associated with tobacco product harm judgment uncertainty. Conclusions Tobacco product harm perceptions are associated with beliefs about tobacco product regulation by the FDA. These findings suggest the need for increased public awareness and understanding of the role of tobacco product regulation in protecting public health.

AB - Background The Family Smoking Prevention and Tobacco Control Act granted the Food and Drug Administration (FDA) the authority to regulate tobacco products in the U.S. However, little is known about how regulation may be related to judgments about tobacco product-related risks. Purpose To understand how FDA tobacco regulation beliefs are associated with judgments about tobacco product-related risks. Methods The Health Information National Trends Survey is a national survey of the U.S. Adult population. Data used in this analysis were collected from October 2012 through January 2013 (N=3,630) by mailed questionnaire and analyzed in 2013. Weighted bivariate chi-square analyses were used to assess associations among FDA regulation belief, tobacco harm judgments, sociodemographics, and smoking status. A weighted multinomial logistic regression was conducted where FDA regulation belief was regressed on tobacco product judgments, controlling for sociodemographic variables and smoking status. Results About 41% believed that the FDA regulates tobacco products in the U.S., 23.6% reported the FDA does not, and 35.3% did not know. Chi-square analyses showed that smoking status was significantly related to harm judgments about electronic cigarettes (p<0.0001). The multinomial logistic regression revealed that uncertainty about FDA regulation was associated with tobacco product harm judgment uncertainty. Conclusions Tobacco product harm perceptions are associated with beliefs about tobacco product regulation by the FDA. These findings suggest the need for increased public awareness and understanding of the role of tobacco product regulation in protecting public health.

UR - http://www.scopus.com/inward/record.url?scp=84925367903&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925367903&partnerID=8YFLogxK

U2 - 10.1016/j.amepre.2014.10.026

DO - 10.1016/j.amepre.2014.10.026

M3 - Article

C2 - 25726094

AN - SCOPUS:84925367903

VL - 48

SP - 445

EP - 451

JO - American Journal of Preventive Medicine

JF - American Journal of Preventive Medicine

SN - 0749-3797

IS - 4

ER -